PRICE T ROWE ASSOCIATES INC /MD/
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in ARQT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,559,756
-$23,310,989 QoQ
Shares Held
448,207
-61.6% QoQ
Ownership
0.358%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $13,950,986,356 across 255 Biotechnology names. ARQT ranks #102 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,206,618 | $305,117,340 |
All Filings in ARQT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,559,756 | 448,207 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $33,870,745 | 1,166,348 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,655,067 | 87,802 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,178,338 | 84,047 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,218,981 | 77,940 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $589,921 | 42,349 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $559,376 | 60,148 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $547,788 | 58,902 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $473,232 | 47,753 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $148,812 | 46,072 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $121,848 | 22,947 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $212,757 | 22,325 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $217,415 | 19,765 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $284,840 | 19,246 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,426,307 | 179,294 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,654,644 | 453,057 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,642,000 | 448,702 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $17,072,504 | 823,168 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $19,439,149 | 813,694 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $25,242,103 | 924,958 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $18,990,259 | 656,421 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,392,029 | 262,781 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $29,036,915 | 991,021 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $32,252,169 | 1,066,540 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $29,222,297 | 980,614 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||